, accompanied by up-regulation of dopamine uptake (Mash et al., 1997) . Such functional alterations could be important, perhaps contributing to cocaine-induced binging, withdrawal symptoms, or craving. Beyond drug self-administration, dopamine neurons play a role in other rewarding phenomena, including sex (Everitt, 1990) and eating (Phillips et al., 1993) , suggesting that regulatory alterations in DAT function could have interesting implications for understanding the dynamics of a number of motivational and appetitive processes. Recent experiments in cell culture have determined that phosphorylative treatments (Pristupa et al., 1998; Daniels et al., 1999; Melikian and Buckley, 1999) or exposure to the stimulant d-amphetamine (Saunders et al., 2000) dynamically regulate DAT function by changing DAT cellular localization, perhaps invoking mechanisms that might be related to those activated by cocaine.
Clinical studies indicate that human cocaine users dying during exposure to cocaine have increased striatal [ 3 H]WIN 35428 binding to the dopamine transporter (DAT; Little et al., 1993 Little et al., , 1999 Staley et al., 1994) , accompanied by up-regulation of dopamine uptake (Mash et al., 1997) . Such functional alterations could be important, perhaps contributing to cocaine-induced binging, withdrawal symptoms, or craving. Beyond drug self-administration, dopamine neurons play a role in other rewarding phenomena, including sex (Everitt, 1990) and eating (Phillips et al., 1993) , suggesting that regulatory alterations in DAT function could have interesting implications for understanding the dynamics of a number of motivational and appetitive processes. Recent experiments in cell culture have determined that phosphorylative treatments (Pristupa et al., 1998; Daniels et al., 1999; Melikian and Buckley, 1999) or exposure to the stimulant d-amphetamine (Saunders et al., 2000) dynamically regulate DAT function by changing DAT cellular localization, perhaps invoking mechanisms that might be related to those activated by cocaine.
Understanding the mechanisms involved in DAT binding site changes is important because 1) binding site alterations are the primary alterations documented in postmortem brain from cocaine users; 2) DAT inhibitors/ligands are being developed extensively as both therapeutic and imaging agents for both the DAT as well as dopamine neurons; and 3) DAT regulation may provide broader insights into the pharmacological effects of drugs on transporter binding sites. In addition to our need to uncover cocaine's neurochemical effects that provoke symptoms associated with its dependence, it is possible that new therapeutic or imaging agents (many of which are often DAT uptake inhibitors) might themselves induce adaptations in DAT function, as well as alter cocaine's effect on dopamine uptake. Also, potentially, DAT inhibitor binding sites could be altered through some mechanism that is independent of changes in DAT concentration or function.
Human experiments examining the effects of cocaine on DAT regulation (Hurd and Herkenham, 1993; Hitri et al., 1995; Wilson et al., 1996) , as well as a number of animal experiments (Kula and Baldessarini, 1991; Benmansour et al., 1992; Alburges et al., 1993; Koff et al., 1994; Wilson et al., 1994; Hitri et al., 1996; Pilotte et al., 1996; Letchworth et al., 2000) , have found variability in DAT binding levels after cocaine administration, for reasons that remain unclear. Animal experiments have varied a great deal in the dose, route, and length of cocaine administered, the withdrawal time after cocaine exposure, as well as the radioligand used to examine binding changes, and any of these and other factors may have contributed to the varied results. Although the literature is complex, relatively higher cocaine doses and longer treatment courses have seemed necessary to induce increases in DAT binding in animals (Alburges et al., 1993; Koff et al., 1994; Wilson et al., 1994; Hitri et al., 1996; Letchworth et al., 2000) . Also, because some radioligands (such as [ 3 H]WIN 35428) seem more likely to demonstrate cocaine-induced increases than others (such as [ 3 H]mazindol), this suggest that changes in DAT compartmentalization, rather than total synthesis, may be involved. Although cocaine interferes with d-amphetamine-induced DAT internalization (Saunders et al., 2000) , no previous experiments have determined if there are effects of cocaine alone on DAT trafficking.
Previously, the pharmacological resemblance of [ 3 H]WIN 35428 binding to DAT expressed in a cell culture system employing neuro2A cells (N2A, derived from mouse neuroblastoma) to that in human brain, has been documented . Preliminary data also indicated that alterations in [ 3 H]WIN 35428 binding occurred after a 24-h exposure to cocaine, a period of time longer than that reported for d-amphetamine effects in another model system (after 1 h, there were substantial declines in dopamine uptake; Saunders et al., 2000) . The present experiments were designed to determine the dose response and time dependence of cocaine effects on DAT binding sites, the degree to which binding site changes paralleled dopamine uptake changes, and the mechanism involved. Our initial hypothesis was that [
3 H]WIN 35428 binding and [ 3 H]dopamine uptake would be increased by exposure to cocaine through alterations in DAT cellular trafficking, rather than increased protein synthesis. To test this theory, experiments assessed total DAT protein, DAT mRNA, and the subcellular localization of DAT after cocaine treatment. Follow-up experiments searched for a possible role of dopamine in modulating the effects of cocaine on the DAT.
Materials and Methods
hDAT-Transfected Cell Cultures. As described previously , N2A cells were obtained from American Type Culture Collection (Manassas, VA). Briefly, the cells were grown in Opti-MEM I (Invitrogen, Carlsbad, CA)/10% FBS/1% penicillinstreptomycin in 75-cm 2 flasks. After reaching confluence (about 3 days of growth), the cells were collected by trypsinization and transfected with hDAT-cDNA [provided by Zdenek Pristupa (University of Toronto, Toronto, ON, Canada), cloned into the pcDNA3 plasmid]. Transfection was accomplished by electroporation employing a BTX Electroporation System 600 (Biotechnologies and Experimental Research, Inc., San Diego, CA). After selection with Geneticin over several weeks, cells were grown to confluence and then distributed in 24 well plates and allowed to reattach for 24 h before all assays described below. After cocaine or vehicle treatment as described below, cells were thoroughly washed to remove residual cocaine before assay.
Radioligand Binding Assays. (Little et al., 1993 (Little et al., , 1999 (Little et al., 1999) . Both one-site (Wilson et al., 1996a; Xu and Reith, 1997) and two-site models (Madras et al., 1989; Staley et al., 1994) have been reported for [
3 H]WIN 35428. Detection of one versus two sites depends on fairly subtle differences in assay characteristics (Coffey and Reith, 1993; Xu and Reith, 1997 Ci/mmol; PerkinElmer) was added to wells to reach a final concentration of 10 nM and total volume of 0.5 ml (Krebs phosphate buffer), followed by incubation for 5 min (uptake linear) at 37°C on a plate shaker. Uptake was terminated by removing assay medium immediately after incubation using a Brandel 48-well cell harvester, followed by two washes with 1 ml of ice-cold Krebs phosphate buffer. hDAT-N2A cells were then dissolved in 0.8 ml of 1% SDS. The entire liquid content of each well was transferred to a scintillation vial and assayed for radioactivity with 5 ml of CytoScint cocktail (EcoLite; ICN Biomedicals, Costa Mesa, CA) by liquid scintillation counting in an IC spectrometer (model LS 6500; Beckman Coulter, Fullerton,CA). Nonspecific uptake was defined with 30 M (Ϫ)-cocaine. Protein concentrations were again determined using a commercial assay kit (Bio-Rad).
Western Blots. Proteins were extracted, diluted in sample buffer, incubated at 100°C for 5 min, and separated by SDS-polyacrylamide gel electrophoresis (PAGE) using a 7.5% polyacrylamide solution. Proteins were then electrophoretically transferred to nitrocellulose membranes at 60 mA overnight. Blots were incubated with 5% (w/v) nonfat dry milk in TTBS buffer (0.1% Tween 20, 0.15 M NaCl, and 10 mM Tris-HCl, pH 7.4) for 1 h. Rabbit anti-hDAT carboxy-terminal polyclonal antibody (Chemicon, Inc., Temecula, CA) was diluted with 1% bovine serum albumin in TTBS buffer (1:1000), incubated with the blots for 1 h, and gently washed with TTBS buffer. Alkaline phosphatase-conjugated goat anti-rat IgG (1:5000 dilution; Jackson ImmunoResearch Laboratories, West Grove, PA) was then incubated with blots for 1 h and washed extensively with double distilled H 2 O. The antigen-antibody complex was detected with 5-bromo-4-Ochloro-3-indolylphosphate and nitro blue tetrazolium. All steps were performed at room temperature. The relative optical density of protein bands was quantitated using a MCID image analysis system (Microcomputer Imaging Devices, Ottawa, ON, Canada). In addition, a control experiment was performed to determine whether cocaine exposure had any effect on actin, a ubiquitous cell structural component. After quantification of DAT immunoreactivity (IR), control and cocaine treated membranes from three experiments were Cocaine Regulation of hDAT 437 at ASPET Journals on May 20, 2017 molpharm.aspetjournals.org stripped and reprobed for actin immunoreactivity (antibody from Chemicon, Inc.), using assay conditions similar to those described above.
DAT Cell Surface Biotinylation. Biotinylation of cell surfaceexposed hDAT was performed according to the procedures described by Melikian et al. (1996) . Stock solutions of sulfo-NHS-biotine (200 mg/ml in dimethyl sulfoxide; Pierce, Rockford, IL) were stored at Ϫ20°C before use. hDAT-N2A cells were grown in six-well plates for 24 to 48 h until the wells were confluent. Cocaine (1 M) treatment was applied for 24 h before biotinylation. After treatment, cells were washed four times with 1 ml of ice-cold calcium-and magnesiumsupplemented PBS (Ca/Mg-PBS, 138 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 9.6 mM Na 2 HPO 4 , 1 mM MgCl 2 , 0.1 mM CaCl 2 , pH 7.3). Sulfo-NHS-biotin solution (1 mg/ml) in Ca/Mg-PBS was incubated with cells for 1 h at 4°C with agitation. Free sulfo-NHS-biotin was removed by washing with ice-cold 0.1 M glycine in 1 ml Ca/Mg-PBS twice. The reaction was further quenched by incubation with 0.1 M glycine for 30 min and then cells were washed with Ca/Mg-PBS three times. Biotinylated cells were solubilized in 0.5 ml of radioimmunoprecipitation assay buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate), supplemented with protease inhibitor (1 M/ml pepstatin, 1 M/ml leupeptin, and 2 mM phenylmethylsulfonyl fluoride) for 1 h at room temperature with gentle shaking. The lysis samples were centrifuged at 20,000g for 30 min at 4°C to pellet nonsolubilized material. Supernatant was incubated with monomeric avidin beads (300 g of protein/250 g of beads, Pierce) for 1 h at room temperature to separate biotinylated from nonbiotinylated protein. Beads were washed four times with 1 ml of radioimmunoprecipitation assay buffer and the biotinylated proteins were eluted with 100 l of Laemmli SDS-PAGE sample buffer for 30 min at room temperature. Samples of total cell lysates (45 l), lysates after incubation with avidin beads, and the bead eluate were separated by SDS-PAGE and then quantitated, as described above under Western blots. A preliminary control experiment assessed the extracellular specificity of the biotinylation process, by treating whole cells with biotin, followed by centrifugation to separate plasma membrane and cytoplasmic components (initially 2000g for 2 min to pallet debris and undestroyed cells, followed by centrifugation of the collected supernatant at 4000g for 2 min to pellet a crude fraction showing a high content of plasma membrane). The two fractions (2-g pellet and supernatant) were electrophoresed by SDS-PAGE, then stained with streptavidin-conjugated horseradish peroxidase, which was detected by electrochemical luminescence. Numerous biotinylated bands were present in the plasma membrane fraction and none in the cytoplasmic fraction.
Immunofluorescence/Confocal Microscopy. hDAT-N2A cells were grown on Corning cover slips for 24 to 48 h and then appropriately treated in three ways: with vehicle, with 1 M cocaine for 24 h, or with 5 M PMA for 30 min. The cover slips were then fixed with 3.5% formaldehyde for 30 min and permeabilized with 0.2% saponine in phosphate-buffered saline (PBS) for 10 min, repeated once. Incubation was performed using a primary rat anti-hDAT N-terminal monoclonal antibody at 1/80 dilution for 2 h (Chemicon International Inc.). This antibody was used instead of the rabbit anti-hDAT Cterminal polyclonal because it demonstrated lower levels of diffuse background labeling. Slides were then incubated with a secondary lissamine rhodamine-conjugated goat anti-rat antibody at 1/100 dilution for 2 h (Jackson, West Grove, PA). Subcellular localization of immunofluorescently labeled hDAT was determined with an MRC-600 Confocal Imaging System (Bio-Rad). The laser beam was consistently calibrated and centered to obtain maximal brightness with minimal background. Slides were exposed to UV light for limited time periods of similar duration for each treatment group. Each cell with distinct membranal labeling in the same nondividing growth stage was uniformly included. Eight to ten digitized images were made through each cell at 0.1-m intervals. The image of greatest horizontal extent was quantified using the MCID image analysis system, which determined the relative optical density within a cursor-determined area. Three areas were identified and quantitated for each cell: outer rim (which was always very distinctly labeled), large inclusions (which seemed to include the Golgi), and background cytoplasm. Control nontransfected N2A cells did not display labeling. Slides were quantified from three independent experiments. The results from each experiment were compared; densities obtained from individual cells across experiments were summed. A total of approximately 20 to 30 cells were quantified from each treatment group. The density of DAT immunofluorescence was quantified blind to treatment condition.
Northern Blots. Total RNA was extracted from N2A cell culture with TRIzol reagent (Invitrogen). RNA were separated by electrophoresis through agarose gels containing formaldehyde and transferred to nylon membranes (positively charged) overnight by the capillary method. After transferral, the blots were UV cross-linked. A 45-base oligonucleotide probe (AGA GCA GCA CGA TGA CCA GCA CCA GGC AGG CTG TGA GCT GCC ACC) complementary to bases 710 to 754 of the human dopamine transporter cDNA was synthesized and labeled at the 5Ј-end with biotin. Hybridization with oligonucleotide probe was carried out at 37°C overnight. The blots then were washed twice in 2ϫ SSC/0.1% SDS, pH 7.0, at room temperature for 5 min each and another two times in 0.5ϫ SSC/0.1% SDS, pH 7.0, at 37°C for 15 min each. The streptavidin/alkaline phosphatase conjugate was used for the detection of biotin-labeled nucleic acid, followed by incubation with CDP-star, an ultra-sensitive chemiluminescent substrate for alkaline phosphatase. The nylon membranes were then exposed for 2 to 7 min to chemiluminescent detection film at room temperature. The relative optical density of RNA bands was again quantitated using the MCID image analysis system.
[ 3 H]Leucine Uptake. hDAT-N2A cells were plated in 24-well plates and treated with 1 M cocaine or vehicle for 24 h. After treatment, cells were thoroughly washed with dopamine uptake buffer (120 mM NaCl, 4.8 mM KCl, 1.4 mM MgSO4, 16 mM Na2HPO4, 11.1 mM dextrose, 1 mm ascorbic acid, 0.03 mm pargyline, and 1.2 mM CaCl 2 , pH 7.4). [ 3 H]Leucine (150 Ci/mmol; PerkinElmer) was added to wells to reach a final concentration of 1 nM and a total well volume of 0.5 ml, followed by incubation for 7 min at 37°C on a plate shaker. Varying concentrations of leucine were added (10 nM-100 M) to each group of three wells. Nonspecific uptake was defined with either 10 mM glutamine or lysine (both found equivalent). Uptake was terminated by removing assay medium immediately after incubation, followed by two washes with buffer. Cells were dissolved in 0.55 ml of 2% SDS. The entire content of each well was transferred to a scintillation vial and assayed for radioactivity by liquid scintillation.
Inhibition of Protein Synthesis. Rates of incorporation of [ 3 H]leucine were determined after treatment with varying doses of cycloheximide, in a range of doses (0.1 to 10 M) previously documented to curtail protein synthesis (Alirezaei et al., 1999) . hDAT-N2A cells were grown in six-well culture plates and treated with cycloheximide for 24 h at 37°C. Cells were then washed twice with 1 ml of HEPES buffer (20 mM HEPES, 5.5 mM glucose, 120 mM NaCl, 5.5 mM KCl, 0.9 mM MgCl 2 , and 1.1 mM CaCl 2 , pH 7.4) and incubated for 30 min in this medium in the presence of 5 M leucine. [ 3 H]Leucine (150 Ci/mmol; PerkinElmer) was added to a concentration of 1 Ci/ml and incubated for an additional 30 min. Labeling was terminated by two washes in 1 ml of ice-cold phosphate-buffered saline. Ice-cold trichloroacetic acid (1 ml; 10% w/v) was added to each well. Cells were scraped and suspensions were centrifuged for 10 min at 10,000g. The radioactivity of the supernatant and pellet were counted separately by liquid scintillation. The ratio between [ 3 H]leucine incorporated into proteins (pellet) and [ 3 H]leucine taken up into cells (supernatant) was then determined.
Serum-Free Medium versus FBS. Because others have reported that FBS contains serotonin and norepinephrine (Dibner and Insel, 1981; Cutz et al., 1985) , we assayed FBS and found it to contain dopamine and serotonin (levels reported below). Cell expres- sion systems commonly use FBS because serum-containing medium strongly contributes to the rapid and healthy growth of cells in culture. However, based on the levels discovered in FBS, and the possibility that dopamine or serotonin may have played a role in cocaine regulation (perhaps by decreasing uptake after intracellular transport, an effect which might then be blocked by cocaine), two additional experiments were performed: 1) dose response studies, using 10 Ϫ8 to 10 Ϫ5 M concentrations of dopamine and serotonin; and, 2) cocaine treatment in serum-free medium (Neurobasal medium, N-2 supplement, L-glutamine; Invitrogen).
HPLC Assay . FBS and Opti-MEM samples were assayed using a mobile phase buffer of: 0.1 M citrate, 0.075 M sodium phosphate, 0.75 mM sodium heptanesulfonate, and 17% methanol (v/v), adjusted to pH 4.12. A C18 chromatographic column with 5-m microparticulate silica gel (Spherisorb ODS-2; SigmaAldrich Chromatography) was used. Separations were performed isocratically at a flow rate of 1.0 ml/min employing a pump and controller from Waters (Milford, MA) coupled to an electrochemical detector (potential maintained at 0.35 V; Coulochem model 5100A; ESA, Bedford, MA). Standard calibration curves were prepared as peak area (V ⅐ s/10 Ϫ6 ) versus concentration of neurotransmitter (ng/l) and the concentrations of neurotransmitters and metabolites in samples were then back-calculated. Retention times were distinct for each compound analyzed. Chemicals, along with HPLC grade methyl alcohol and water, were obtained from Sigma Chemical Co.
Data Analysis. Computer analysis of radioligand binding and uptake data were performed with Prism v2.0 (GraphPAD Software, San Diego, CA), using iterative curve-fitting techniques. A coefficient of determination was calculated for each set of data as an indicator of how well the data fit the function, similar to a correlational coefficient. Saturation and competition data were fit to one-or twocomponent models and evaluated for goodness-of-fit by Sheffé's F test. B max , K d , and K i were thus determined. Experiments involving multiple conditions, both cocaine dose and hours of treatment, were analyzed using a repeated-measures, two-way ANOVA model, followed by Tukey's multiple comparison tests. In those experiments involving comparisons between two paired wells, paired Student's t test was used. Experiments involving one treatment time with multiple treatments were analyzed using a one-way ANOVA model, followed by Dunnett's multiple comparison tests. For every experimental issue addressed, at least three independent experiments were performed (the degrees of freedom are noted below with the data for each experiment). Figure 3 demonstrates that the changes in binding were paralleled by increases in dopamine uptake V max . The increase seemed to occur at an increased rate compared with the induced binding changes, reaching statistical significance at 3 h. The increases in V max were of a similar magnitude as the After removal of cocaine (see Fig. 4 ), cocaine-induced increases in DAT binding sites returned to baseline over the next 24 h. Re-exposure to cocaine on the second day after withdrawal, at the same dose, invoked up-regulation again, of a similar magnitude (about 30%), compared with control cells (data not shown).
Results

Effects of Cocaine
Because a Tris buffer has been used to assess cocaine effects on DAT regulation in the past (Little et al., 1993 (Little et al., , 1999 , and the inclusion of Tris in assay buffer has been found to decrease absolute B max for DAT binding sites (Reith et al., 1984) , experiments were performed examining the effect of cocaine exposure on DAT binding in an assay buffer containing 50 mM Tris/120 mM NaCl, instead of the phosphate/sucrose buffer. In these experiments (n ϭ 3), [ Effects of Cocaine Treatment on Total DAT Concentrations, DAT mRNA, and Subcellular Location. A preliminary biotinylation experiment found that 64% of hDAT was intracellular and 36% on the surface basally in the hDAT-N2A cells [based on quantified relative optical densities (RODs); see Fig. 5A ]. Further experiments conducted after 24 h of treatment with 1 M cocaine, determined that cocaine-induced increases in hDAT function did not involve an increase in synthesis of DAT molecules. Western blots of the DAT showed no increase in total DAT immunoreactivity after cocaine exposure (1 M for 24 h; see Fig. 5B ), but surface hDAT, as measured by biotinylation, was significantly increased (biotinylated DAT IR 0.39 Ϯ 0.03 ROD in vehicle-treated cells versus 0.50 Ϯ 0.04 in cocaine-treated (t ϭ 2.40, df ϭ 7, p ϭ 0.04). Consistent with these results suggesting that trafficking mechanisms were involved was a clear visual increase in DAT-immunoreactive labeling of the outer rim of cocaine-treated cells (as shown in Fig. 6 ). When digitized and quantitated, this effect was found to be statistically significant (see Fig. 7 ). Conversely, DAT immunofluorescence was mildly decreased intracellularly. Control experiments that involved treating hDAT-N2A cells with PMA (5 m for 60 min) caused statistically significant increases in cytoplasmic and large inclusion DAT immunofluorescence, with a trend noted toward decreased outer membrane DATimmunofluoresence. Figure 8 demonstrates the appearance of hDAT immunofluorescence through the extent of a cocaine-treated cell with a series of z-sections.
DAT mRNA levels were found to be similar to control cells 24 h after cocaine exposure (again, 1 M cocaine dose; see Fig. 9 ). Other experiments using cycloheximide treatments demonstrated that cocaine-induced increases in [ 3 H]WIN 35428 binding were not blocked by the inhibition of new protein synthesis (Fig. 10B) . Also, a control experiment demonstrated that cocaine did not effect [ 3 H]leucine uptake ( Fig.   Fig. 3 . Time course of cocaine effects on [ 3 H]dopamine uptake V max in hDAT-N2A cells. Cells were grown to confluence, then treated with fresh medium containing either cocaine or the same volume of medium only. Cells were initially treated with cocaine, 10 Ϫ6 M for the indicated time periods, from 0.5 to 48 h. Cells used in the 48-h experiment were washed after 24 h and supplied with fresh cocaine or vehicle. Eight concentrations of [ 3 H]dopamine were used in each experiment, and the data were fit to a one-site model. Three to five pairs of independent saturation experiments were performed at each time point, and the raw data was analyzed as matched pairs. A repeated-measures, two-way ANOVA found there were significant cocaine (df ϭ 15,1, F ϭ 6.88, p ϭ 0.01) and time effects (df ϭ 15,7, F ϭ 4.38, p Ͻ 0.001) on [ 3 H]dopamine V max . Follow-up paired t-tests found there were significant cocaine effects at 3 (t ϭ 3.10, p ϭ 0.05), 6 (t ϭ 3.28, p ϭ 0.04), 12 (t ϭ 4.00, p ϭ 0.03), 24 (t ϭ 6.67, p ϭ 0.007), and 48 h (t ϭ 5.24, p ϭ 0.01). There were no effects on binding affinity (see Table 1 ). Possible Role of Phosphorylation. As shown in Fig. 11 , cells treated with cocaine (1 M ϫ 24 h, and demonstrating increased DAT function) showed no change in their responsiveness to treatment with PMA, which has been shown to cause internalization of DAT via protein kinase C phosphorylation (Pristupa et al., 1998) .
Possible Involvement of Dopamine and Serotonin as Intracellular Messengers. Because it was possible that the effect of cocaine depended on reversing the basal suppression of hDAT expression by low levels of dopamine present in serum, further experiments incubating hDAT-N2A cells with dopamine for 24 h in concentrations from 10 Ϫ8 to 10 Ϫ5 M were performed. An inhibiting effect on [ 3 H]WIN 35428 binding was found only at the highest concentration (see Table 1 ). There was no evidence of cell toxicity, as measured by total protein, which was equivalent to controls at all four concentrations of dopamine. The presence of residual dopamine possibly contributed to the decrease in [
3 H]WIN 35428 binding seen at 10 Ϫ5 M, although dopamine concentrations were probably much diluted. Incubation with the same concentration range of serotonin found no diminishment in [
3 H]WIN 35428 B max or affinity, nor any change in total protein levels. One other indicator that dopamine played no role in cocaineinduced trafficking, hDAT-N2A neurons grown in serum-free medium (which is dialyzed to remove any trace levels of dopamine), demonstrated a similar pattern of cocaine-induced DAT increases.
HPLC assay found that fetal bovine serum contained considerably lower levels of dopamine (0.125 Ϯ 0.077 M, three samples) and serotonin (3.57 Ϯ 1.33 M, three samples) than required to suppress hDAT levels in the above experiments.
When used with N2A cells, the levels of dopamine and serotonin in FBS were further diluted to 1/10 with Opti-MEM (which did not contain measurable dopamine or serotonin). Average levels of dopamine and serotonin in FBS present in cell cultures over 24 h were probably even lower than initial levels; recent experiments have shown that catechol-O-methyltransferase actively degrades monoamines in several cell cultures expressing recombinant DAT cDNA (Eshleman et al., 1997) . In any case, as shown in Fig. 12 
Discussion
The present experiments extend our earlier report in N2A cells , and model features that have been discovered in postmortem specimens from human cocaine users, including increased [ 3 H]WIN 35428 binding (Little et al., 1993 (Little et al., , 1999 Staley et al., 1994) Non Trans ϭ N2A without pcDNA3-hDAT transfection. A striatal sample from human striatum is also included for comparison. B, scanned image illustrating hDAT immunoreactivity after cocaine exposure, 1 M ϫ 24 h (cell surface ϭ biotinylated fraction). There was an increase in the density of the cell surface band after cocaine treatment. This was consistently present in four independent experiments: cell surface DAT immunoreactivity (IR) 0.39 Ϯ 0.03 (ROD) control versus 0.50 Ϯ 0.04 cocaine (t ϭ 2.40, df ϭ 7, p ϭ 0.04). Intracellular DAT IR was not significantly decreased: 0.69 Ϯ 0.05 control versus 0.60 Ϯ 0.08 cocaine (t ϭ 0.69, df ϭ 8, p ϭ 0.36).
There was no effect of cocaine treatment on total hDAT IR: 1.67 Ϯ 0.03 control versus 1.70 Ϯ 0.04 cocaine (t ϭ 0.85, df ϭ 8, p ϭ 0.42). The gel image is overexposed to highlight the surface DAT comparison, but total IR was also quantitated on film with shorter exposures to assure that the films were not saturated. uptake (Mash et al., 1997) , without increases in DAT mRNA .
A number of independent measures demonstrated the presence of increased, functional DAT after cocaine treatment. This increase seemed restricted to the cell surface, based on biotinylation and confocal microscopic results. The lack of change in DAT mRNA or total protein levels, and the failure of cyclohexamide treatments that markedly inhibited protein synthesis to block the effects of cocaine, further indicate there was no change in total number of DAT molecules. Other control experiments indicate that the effect of cocaine was specific to the DAT because cocaine treatment caused no changes in [ 3 H]leucine uptake or actin protein levels. The magnitude of the increases detected with the various measures were similar at 24 h, with a 37% increase recorded in dopamine V max , a 34% increase in [
3 H]WIN 35428 B max , a 35% increase in outer membranal labeling using confocal microscopy, and a 28% increase in biotinylated hDAT. The small differences probably reflect to some degree differences between measures in their selectivity for membrane-inserted hDAT versus internalized hDAT. Although the decrease in nonbiotinlylated DAT after cocaine treatment was not statistically significant on Western blots, this probably reflects the much larger intracellular volume and greater absolute amounts of intracellular DAT, compared with that of the plasma membrane, and would have been expected to demonstrate smaller percentage changes after cocaine treatment.
The present results can be compared with those reported by Saunders et al. (2000) using hDAT-FLAG expressed in human embryonic kidney 293-EM4 cells. These investigators found that 2 M d-amphetamine increased internalization of surface DAT within 1 h on confocal microscopy and in wholecell current recordings. We have also noted an opposite effect of d-amphetamine on hDAT binding compared with (-)-cocaine It is possible that markedly distinct mechanisms are at play in the processes noted here versus those caused by d-amphetamine as described by Saunders et al (2000) . However, cocaine-induced redistribution of DAT to the surface might involve similar pathways and seem slower in hDAT-N2A cells than DAT internalization in d-amphetaminetreated EM4 cells simply because of relative differences in basal state DAT distribution patterns for the two types of cells. In contrast to hDAT-N2A cells, EM4 cells displayed very little internal DAT fluorescence basally. Thus, the kinetics of surface versus intracellular distribution seem to favor a membrane locale in EM4 cells, an ideal situation for measuring shifts toward intracellular accumulation. In contrast, in the hDAT-N2A cells, which basally display more intracellular hDAT, redistribution effects may take longer to detect because of the more even distribution between the two compartments. Daniels et al. (1999) have recently described PMA-induced trafficking of a green fluorescent protein-tagged DAT expressed in Madin-Darby canine kidney cells. Similar to the cells used by Saunders et al. (2000) , these cells display little basal intracellular DAT fluorescence, which markedly increases after PMA treatment. In contrast, Melikian and Buckley (1999) , using the same hDAT-pcDNA3 construct as presently described, transfected into a neuronal cell PC12, reported that 63% of hDAT IR was intracellular in studies employing biotinylation and sucrose gradient ultracentrifugation. Together, these results suggest that tagged DAT may have a shorter half-life after internalization and increased lysosomal degradation rates compared with untagged DAT. Supporting this idea, Daniels and Amara (1999) found that 0.1 M PMA treatment for 1 h caused extensive DAT-green fluorescent protein fluorescence colocalized with AC-17 (antilysosomal glycoprotein antibody)-labeled vesicles and a considerable loss of total DAT IR on Western blots. Conversely, Melikian and Buckley (1999) , working with untagged DAT, found that 30 min of 1 M PMA induced internalization of DAT IR that was nearly all concentrated in the transferrinlabeled recycling compartment, not in the EEA1-labeled slow Fig. 9 . A, digital image illustrating hDAT mRNA bands detected on electrophoretic gel: (Ϫ)-cocaine treatment, 1 M for 24 h; NT, N2A cells without hDAT transfection; SN, sample from human substantia nigra. B, graph depicting the results of three independent experiments. Gel results were digitized and the relative optical densities for each band quantitated and compared. There was no effect of cocaine treatment on hDAT mRNA band density (cocaine-treated versus control, t ϭ 0.768, df ϭ 4, p ϭ 0.48). Moderate doses of dopamine or serotonin did not effect the DAT. If an inhibiting effect had existed, then the presently described cocaine increases might have reflected a reversal of an intracellular dopamine effect. Further indicating that dopamine was not involved in the presently described trafficking phenomenon, hDAT-N2A neurons grown in serum-free medium also demonstrated cocaine-induced up-regulation. In a previous report, Saunders et al. (2000) found that 100 M dopamine for 1 h increased DAT internalization in a manner similar to 2 M d-amphetamine. These results seem consistent with the present findings, which found that high doses of dopamine decreased [ 3 H]WIN 35428 binding, after a longer treatment period.
The quantification of immunofluorescence by confocal microscopy can be confounded by a number of factors including inadequate matching of the 3D plane, differences in cell growth, and the fading of immunofluorescence, among others (Nagelhus et al., 1996) . Although the present experiments may not have eliminated all the variability caused by these factors, the quantification of different treatment groups was carefully balanced. The cocaine-induced increase in plasma membrane and decrease in large inclusion-associated immunofluoresence were consistent with the biotinylation results, which found increased cell surface DAT, no increase in total DAT, and a trend toward decreased intracellular DAT.
Previous experiments have alternatively used either sucrose/phosphate buffer or Tris buffer (Madras et al., 1989; Little et al., 1993; , with some evidence suggesting that a two-site model is more likely in low sodium buffers, perhaps partly because of binding to filter paper (Chen et al., 1997) . Although Tris decreases total DAT binding (Reith et al., 1984) Little et al., 1999) . Dopamine uptake affinity in the hDAT-N2A cells has varied in the 200 to 500 nM range in our laboratory over a period of several years, and the range of [ 3 H]dopamine Although a comparison of dose concentrations and time scales between cells in culture and living animals or humans is inexact, the present results parallel animal experiments finding that relatively large cumulative doses of cocaine (generally more than 200 mg/kg/rat) are required to consistently cause DAT up-regulation (Alburges et al., 1993; Koff et al., 1994; Wilson et al., 1994; Hitri et al., 1996; Letchworth et al., 2000) . However, the 1 M cocaine dose repeatedly administered in the present study is within the range reported in blood or brain from human cocaine users (generally 0.1 to 1 M range, Foltin and Fischman, 1991; Isenschmid et al., 1992; Lukas et al., 1996) .
In summary, cocaine treatment of hDAT-N2A cells models features detected in postmortem striatal samples from human cocaine users and suggests a possible mechanism for the observed increases in [
3 H]WIN 35428 binding. Cocaine regulation of DAT trafficking in hDAT-N2A neurons did not require the mediation of dopamine, but it is possible that intact dopamine neurons incorporate mechanisms for adjusting DAT function based on dopamine levels. The present model system should prove useful in better understanding the complex relationship between alterations in DAT radioligand binding and DAT protein trafficking. Confusion about these phenomena probably contributes to the current conflicting interpretations of existing in vitro and in vivo radioligand experiments.
